Biotechnology News

Fri, 2014-03-14 12:02

LEXINGTON, Mass.--(BUSINESS WIRE)--Wendell Wierenga joins Concert Pharmaceuticals board of directors.

Fri, 2014-03-14 12:02

HOLLISTON, Mass.--(BUSINESS WIRE)--Harvard Apparatus Regenerative Technology has posted the latest version of its investor presentation on its website.

Fri, 2014-03-14 12:02

JERUSALEM--(BUSINESS WIRE)--BioLineRx Announces Issuance of US Patent Covering Use of BL-8040 in Immunotherapy. BL-8040 undergoing Phase 2 trial for acute myeloid leukemia (AML), and expected to commence Phase 1 trial

Fri, 2014-03-14 08:00

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Meda (STO:MEDAA): Meda has entered into a promotion agreement with Mission Pharmacal, a company active in the women’s health area, for Meda’s topical estrogen replacement therapy product...

Fri, 2014-03-14 08:00

MILAN--(BUSINESS WIRE)--Sorin Group Announces the purchase of Oscor Inc. lead business including a lead manufacturing facility in the Domenican Republic for an aggregate value of approximately USD20 million (Eur15.4 million)

Fri, 2014-03-14 08:00

HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News: Karo Bio’s Annual Report 2013 has been published and is available on the company’s website www.karobio.se. About Karo Bio Karo Bio is a...

Thu, 2014-03-13 23:00

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc., an oncology precision medicine biotechnology company, today announced the pricing of an underwritten public offering of 5,245,000 shares of its common stock at a public offering price of $9.15 per share,...

Thu, 2014-03-13 19:00

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced that a study published online in the journal BMC Cancer...

Thu, 2014-03-13 19:00

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc. (NASDAQ: TRVN), a clinical stage pharmaceutical company focused on the discovery and development of G-protein coupled receptor (GPCR) biased ligands, today announced that it will host a...

Thu, 2014-03-13 19:00

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) today announced its financial results for the fourth quarter and year ended December 31, 2013. “2013 was a transformational year for Anacor, as we advanced our two late-...

Thu, 2014-03-13 19:00

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) today announced that it is offering to sell shares of its common stock in a proposed underwritten public offering. All shares to be sold in the offering are being sold by Dyax. The...

Thu, 2014-03-13 19:00

WASHINGTON--(BUSINESS WIRE)--BIO today announced Specialty Forums that will highlight the most pressing health issues facing our industry at the 2014 BIO International Convention® in San Diego.

Thu, 2014-03-13 19:00

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology Reports Full Year 2013 Financial Results and Outlines 2014 Strategic Plan

Thu, 2014-03-13 15:00

PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS announced audited financial results for the year ended Dec. 31, 2013, appointed Marie Meynadier to the Board of Director and has been added to the new Euronext Paris CAC PME index.

Thu, 2014-03-13 15:00

HOUSTON--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, today announced the appointment of John Sedor as a non-executive Director and Chairman of the Compensation Committee of its Board of...

Thu, 2014-03-13 15:00

LAKE OSWEGO, Ore.--(BUSINESS WIRE)--BIOTRONIK, a leading manufacturer of cardiovascular medical devices, announced today that the Food and Drug Administration (FDA) has approved the expansion of BIOTRONIK’s ongoing ProMRI® trial. The new phase of...

Thu, 2014-03-13 15:00

GRAND RAPIDS, Mich.--(BUSINESS WIRE)--Technology furthers our knowledge of the human brain and strengthens it. Learn contemporary brain health options for ADHD, focus, sleep and anxiety at March 18 event with Neurocore in Grand Rapids, MI

Thu, 2014-03-13 15:00

REYKJAVIK, Iceland--(BUSINESS WIRE)--Alvotech, a powerful new player in the field of biopharmaceuticals and Finesse Solutions have entered into a partnership.

Thu, 2014-03-13 15:00

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today a significant collaboration between Teva and the United Kingdom (UK) Government’s National Health Service National Institute for Health Research (NIHR)...

Thu, 2014-03-13 15:00

WASHINGTON--(BUSINESS WIRE)--BIO named DuPont Chair & CEO Ellen Kullman as the recipient of its 2014 George Washington Carver Award for innovation in industrial biotechnology. Kullman is the first woman to receive the honor.

Thu, 2014-03-13 11:01

MILFORD, Conn.--(BUSINESS WIRE)--DNA Sequencing Test ID's New Strain of Lyme Disease Not Detectable in Standard Tests Now in Use

Thu, 2014-03-13 11:01

BALTIMORE--(BUSINESS WIRE)--WellDoc®, developers of the first FDA-cleared, mobile prescription therapy, BlueStarTM, announced today that Kevin P. McRaith has joined the Company as President.

Thu, 2014-03-13 11:01

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida announces $7 million investment by RA Capital

Thu, 2014-03-13 11:01

BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair, based on hyaluronic acid (“HA”) technology, today announced that Genzyme Corporation (plaintiff) and Anika...

Thu, 2014-03-13 11:01

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company developing a portfolio of potent new antibiotics designed to be effective against multidrug-resistant bacteria, today...

Thu, 2014-03-13 11:01

ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc. announced today the release of LifeMap Discovery® version 1.6 (discovery.lifemapsc.com). LifeMap Discovery® is a state-of-the-art roadmap of embryonic development and stem cell biology. The...

Thu, 2014-03-13 11:01

TEL AVIV, Israel--(BUSINESS WIRE)--NanoIsrael 2014: In the six years since declaring nanotechnology as national priority in Israel, the field marked significant achievements

Thu, 2014-03-13 11:01

RALEIGH, N.C.--(BUSINESS WIRE)--DARA BioSciences presents results of CAPTURE registry at NCCN® 19th Annual Conference. The patient survey reveals potential strategies to improve long-term adherence to Tamoxifen based on choice.

Thu, 2014-03-13 11:01

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Theorem Clinical Research has won recognition in all five categories of the 2014 CRO Leadership Awards: Quality, Productivity, Reliability, Innovation and Regulatory.

Thu, 2014-03-13 11:01

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune disorders and genetically defined forms of B-cell...

Thu, 2014-03-13 11:01

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune disorders and genetically defined forms of B-cell...

Thu, 2014-03-13 11:01

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zalicus reports 4th quarter and year ended December 31, 2013 earnings

Thu, 2014-03-13 11:01

BELGRADE, Mont.--(BUSINESS WIRE)--Bacterin International Holdings, Inc. (NYSE MKT: BONE) is pleased to announce the launch of OsteoSTX, a new novel allograft for orthopedic procedures. Utilizing Bacterin’s proprietary demineralization technology...

Thu, 2014-03-13 11:01

HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm announces fourth quarter 2013 and full year 2013 financial results and provides an overview of 2013 highlights.

Thu, 2014-03-13 11:01

NEW YORK--(BUSINESS WIRE)--Actinium Pharmaceuticals, Inc. (OTCQB:ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announces that...

Thu, 2014-03-13 11:01

EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (NASDAQ: ATRS) today reported operating and financial results for the fourth quarter and full year ended December 31, 2013. Recent Highlights Received approval of OTREXUP (methotrexate) injection...

Thu, 2014-03-13 11:01

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Netsmart revenue cycle management services will help behavioral health provider focus on strategic growth and use more revenue for direct services to clients.

Thu, 2014-03-13 11:01

CAMBRIDGE, Mass.--(BUSINESS WIRE)--SAGE Therapeutics Closes $38M Oversubscribed Series C Financing

Thu, 2014-03-13 11:01

--(BUSINESS WIRE)--Rare Disease Day to be held at NJ State House on Thursday, March 13. Brief testimony at 10:00 a.m. followed by educational seminar.

Thu, 2014-03-13 07:00

PITTSBURGH--(BUSINESS WIRE)--Second collaboration between Knopp Biosciences LLC and National Institute of Allergy and Infectious Diseases (NIAID) will investigate the eosinophil-lowering effects of dexpramipexole.

Thu, 2014-03-13 07:00

NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) announced today the appointment of Marino Garcia as Senior Vice President, Corporate Development. In this newly created position reporting directly to the CEO, Mr. Garcia will...

Thu, 2014-03-13 07:00

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories has entered into a definitive agreement to acquire the CRO services division of Galapagos NV, which includes both Argenta and BioFocus, for approximately $179 million

Thu, 2014-03-13 02:03

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles today announced the pricing of a secondary public offering of 15 million shares of its common stock by certain of its shareholders at a price to the public of $52.00 per share.

Wed, 2014-03-12 21:00

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTC/BB: TBIO) today reported financial results for the fourth quarter and year ended December 31, 2013, and provided a business update. Fourth Quarter Financial Results Net sales for the fourth...

Wed, 2014-03-12 17:00

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--The Wake Forest University Biotechnology Conference and Case Competition celebrates its fifth anniversary this year. It will be held March 21-22 at the School of Business.